• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • BioAsia 2023 to be held in February 24-26 in Telangana, India
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE
  • Event: Australia’s biggest week in biotech kicks off in Perth
  • $3 trillion growth reported for biotech sector in USA
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”
  • Vaccination, Rising Deaths, And The False Narrative
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Editorial- Prof. Pallu Reddanna joins Advisory Board of Biotech Express

Editorial- Prof. Pallu Reddanna joins Advisory Board of Biotech Express

0
By Biotech Express on August 18, 2021 Articles, Articles- Editorials

It is my immense pleasure to announce that Prof Pallu Reddanna has joined the Advisory Board of Biotech Express magazine. He is an eminent personality in Life Sciences and a well known name in Biotech Industry. Prof Reddanna is Executive president of FABA and is actively involved in promoting Indian biotech in Asia and around the world.

Kamal Pratap Singh, Managing Editor

Brief Profile: Prof. Pallu Reddanna

Prof. Reddanna was born in Reddivaripalli village, Lakkireddipalle in Kadapa District, Andhra Pradesh, in the year 1954, completed schooling from ZPH School, graduation (1974), post-graduation(1976) and doctoral studies (1979) from Sri Venkateswara University, Tirupati, Andhra Pradesh.

Prof. Pallu Reddanna currently is BSR Faculty Fellow, School of Life Sciences, University of Hyderabad, Hyderabad, India & President of Federation of Asian Biotech Associations (FABA)
Email: prsl@uohyd.ac.in; preddanna@gmail.com

He started his career as lecturer in Zoology (1982-1990) in Sri Venkateswara University before joining as Reader in the School of Life Sciences, University of Hyderabad in 1990. He became Professor in 1998, and later managed the department of Animal Sciences as Head (now Department of Animal Biology) during 1999-2002, Coordinator, Centre for Biotechnology, (now Department of Biotechnology and Bioinformatics) during 2006-2008 and as the Dean, School of Life Sciences (2015-2018) and served as a member of the Executive Council of University of Hyderabad.

Prof. Reddanna served as the Founding Director (2010-2014) of National Institute of Animal Biotechnology (NIAB), Department of Biotechnology, Ministry of Science & Technology, Government of India. Dr. Reddanna was instrumental in establishing the infrastructure, recruiting the scientists and establishing the NIAB in about 100 acres in a record time.

Prof. Reddanna played a key role in promoting innovation and entrepreneurship activities in the University of Hyderabad by establishing NSTEDB supported Technology Business Incubator (TBI) in 2010 and BIRAC supported Biotech Incubation Center (UoH-BioNEST) in 2018. Within a span of three years of the establishment of BioNEST incubator, it has been recognized as the Best BioNEST incubator in the country, under emerging incubators category, in 2021.

As one of the founder members of the Federation of Asian Biotech Associations (FABA) he provided a platform for interactions for the academy, industry and Government bodies not only in India but also in a number of Asian countries. During the 17th edition of BioAsia i.e. BioAsia 2020, FABA Academy was launched, mainly to bridge the gap between academia and industry in Human Resources Development. As part of FABA Academy a number of webinars and workshops are being conducted to help the science graduates in career guidance and skill development activities. More details are available at: https://biofaba.org.in/

Areas of Research:
Prof. Reddanna’s main research focus is on bioactive lipids, prostaglandins and leukotrienes (eicosanoids) formed via cyclooxygenase (COX) and lipoxygenase (LOX) pathways. These eicosanoids play a role in the regulation of variety of physiological processes and their uncontrolled production in some cases is associated with many of the inflammatory disorders, including cancer. As a result, the enzymes- COX and LOX, have become the targets for the development of anti-inflammatory and anti-cancer drugs.

Prof. Reddanna, during his research career over 35 years, has published around 200 papers, guided 41 students for Ph.D and mentored several masters and post-doctoral students. He was successful in collaborating with leading Pharma and Biotech industries like Dr Reddy’s Laboratories Ltd., Dabur India Ltd, Shantha Biotechnics Ltd, Indian Immunologicals, Natco Pharma Ltd, Surya Pharmaceuticals, Onconova Therapeutics, USA etc. Similarly, his service to the promotion of Pharma and Biotech industry in the country was recognized with “Outstanding Contribution Award (Pharma)” in 2005 by the ChemTECH Foundation and “Outstanding Scientist Award for the Benefit of Industry” in 2007 by Federation of Andhra Pradesh Chamber of Commerce and Industry (FAPCCI).

International Exposure
He has visited Countries like USA, Canada, China, UK, Germany, Portugal, Pakistan, France, Israel, Singapore, Malaysia and Iran, Sri Lanka, Japan for academic and industrial purposes. As exchange visitor (1984-87) and as The Rockefeller Foundation Biotechnology Career Awardee (summers of 1992 – 96, 2003 & 2005) at The Penn State University, Prof. Reddanna made significant contributions to the field of eicosanoids. His contributions to the field of lipoxygenases and cyclooxygenases and thus on eicosanoids were recognized with “Royan International Award” in the year 2007.

Research Grants
Government of India – Completed 18 projects funded by: DST (5), DBT (4), CSIR (3), UGC (1), ICMR (4), NMPB (2)

Industries– Completed 13 projects funded by various Biotech and Pharma Industries: Dr Reddy’s Laboratories, Unique Biotech, Shantha Biotechnics Pvt. Ltd., Natco Pharma, Indian Immunologicals, Medgene Biotech, Surya Pharmaceuticals, Laila Impex, Pacific Hospital Pvt Ltd, Institute of Life Sciences, ABL Biotechnologies and Dabur Research Foundation and Onconova Therapeutics (USA), Celestial Labs.

International – Completed 5 projects funded by: Netherlands Biotech Program, The Rockefeller Foundation, Asian Office of Air Force Research and Development (AOARD), Japan; DST-DAAD Sandwich program; IRTG program, Germany

Publications:
Published around 200 papers in peer reviewed journals. H index: 49, i10 index: 137;
Total citations: 8541 (Source: Google Scholar: https://scholar.google.com/citations?user=xCp2iFoAAAAJ).
https://pubmed.ncbi.nlm.nih.gov/?term=reddanna

Important Honours and Awards:

• Founder Director, National Institute of Animal Biotechnology, a Unit of the Department of Biotechnology, Government of India (2010-2014).
• Founder Director, ASPIRE (Association for Scientific Pursuits for Innovative Research Enterprises), a section-8 company established in the University of Hyderabad.
• Executive President, Federation of Asian Biotech Associations (FABA), 2016 onwards
• Vice President, FABA- 2013 to 2016
• Federation of Andhra Pradesh Chambers of Commerce and Industry (FAPCCI) ‘Outstanding Scientist for the Benefit of Industry -2007’
• Royan International Foundation, “ Best Research Project Award- 2007”
• Chemtech Foundation “Pharma Bio Excellence Award” 2005
• The Rockefeller Foundation Biotechnology Career Award (1993-96)
• Ministry of Education & Culture, Govt. of India “ Overseas Post-doctoral Fellowship” (1984-87)
• Council of Scientific & Industrial Research (CSIR), Govt. of India, JRF, SRF & Research Associate Fellowships

Promotion of Biotech Industry:
On behalf of AIBA (All India Biotech Association) & FABA (Federation of Asian Biotech Associations), he was actively involved in organizing various scientific meetings/workshops/conferences. As the Vice-President of AIBA-SC and Member Secretary of FABA, one such major event organized annually is BioAsia, an event promoted by the Government of Andhra Pradesh. BioAsia provides the platform for academia-industry interaction and promotes business partnerships and collaborations. It provides an opportunity for life science companies from around the world to showcase their products, services, technologies and facilitates interactions and business transactions. BioAsia was successful in putting Andhra Pradesh state on world radar and attracting many Pharma and Biotech companies to set up their facilities in the state. To promote entrepreneurship among the scientists, he was instrumental in introducing “BioAsia Innovation Award” for young scientists with a cash prize of Rs. 1,00,000/- and “Young Minds Award” for the best innovations by the High School children with a cash prize of Rs50,000/-. During BioAsia 2020, FABA Academy was launched, mainly to help science graduates in career guidance and skill development activities, through webinars, workshops and conferences.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?

Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE

Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”

Leave A Reply Cancel Reply

Current Issue – October 2022
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
  • India’s Clinical Trial Registry might disappear soon and so the history of pharma record August 19, 2022
  • Nearly Half of Pregnant Women in Pfizer Trial Miscarried August 10, 2022
  • Researchers develop Cellulose shoes made by bacteria August 9, 2022
  • Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility August 5, 2022
  • CBI Arrests of CDSCO officials, a Biocon official & Intermediaries in an alleged bribery case exposed Corruption in Govt and Pharma sector July 27, 2022
  • We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO July 26, 2022
  • EVENT HIGHLIGHTS: Genome editing as a novel technology for sustainable development July 24, 2022
  • US Military Doctor Testifies under Oath That She Was ORDERED To ‘Cover up’ COVID Vaccine Injuries July 24, 2022
  • Climatic Effect on Marine Biodiversity and their impact on coral reefs July 23, 2022
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.